Oxnard R&D Tax Credit for Businesses Explained

R&D Tax Credits for Oxnard, California Businesses

Oxnard, California, is known for its strong presence in agriculture, healthcare, education, and manufacturing. Top companies in the city include St. John’s Regional Medical Center, a major healthcare provider; Oxnard College, a leading educational institution; Haas Automation, a prominent manufacturing company; Del Monte Foods, a key agricultural company; and Naval Base Ventura County, a major military installation. The R&D Tax Credit can help these industries reduce tax liabilities, promote innovation, and enhance business performance.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 115 W California Boulevard, Pasadena is less than 65 miles from Oxnard and provides R&D tax credit consulting and advisory services to Oxnard and the surrounding areas such as: Ventura, Thousand Oaks, Simi Valley, Camarillo and Santa Paula.

If you have any questions or need further assistance, please call or email our local Pasadena Partner on (323) 287-5311.
Feel free to book a quick teleconference with one of our California R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Oxnard, California Patent of the Year – 2024/2025

CURE Pharmaceutical Inc. has been awarded the 2024/2025 Patent of the Year for its innovation in oral vitamin delivery. Their invention, detailed in U.S. Patent No. 11857557, titled ‘Oral dissolvable film containing vitamin D3’, utilizes a dissolvable film technology to stabilize and administer vitamin D₃ effectively.

This new oral dissolvable film (ODF) addresses the instability of vitamin D₃ when exposed to heat, light, moisture, and oxygen. By embedding the vitamin within a specialized polymer matrix, the film preserves its potency and ensures consistent dosing.

Designed for ease of use, the thin film dissolves quickly in the mouth, allowing for efficient absorption without the need for water or swallowing pills. This method simplifies supplementation, particularly for individuals with swallowing difficulties or those seeking convenient alternatives to traditional tablets.

The film’s composition includes sodium carboxymethyl cellulose and polyvinylpyrrolidone for structural integrity, glycerin as a plasticizer, and antioxidants like vitamin E and ascorbyl palmitate to maintain vitamin stability.

Cure Pharmaceutical’s advancement in ODF technology exemplifies a commitment to improving patient compliance and expanding access to essential nutrients. By enhancing the delivery and stability of vitamin D₃, this innovation holds promise for broader applications in nutritional and pharmaceutical products.